Cancer News » adenocarcinoma http://Cancernewsdigest.com Lastest Cancer News: Mesothelioma Lung Cancer, Breast Cancer, Colon Cancer, Skin Cancer, Prostate Cancer & Ovarian Cervical Cancer Thu, 23 May 2013 10:30:59 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 New software identifies and stratifies risk posed by lung nodules http://Cancernewsdigest.com/general-cancer/new-software-identifies-and-stratifies-risk-posed-by-lung-nodules/ http://Cancernewsdigest.com/general-cancer/new-software-identifies-and-stratifies-risk-posed-by-lung-nodules/#comments Mon, 08 Apr 2013 22:36:06 +0000 http://Cancernewsdigest.com/uncategorized/new-software-identifies-and-stratifies-risk-posed-by-lung-nodules/ Scientists have developed a new software tool to noninvasively characterize pulmonary adenocarcinoma, a common type of cancerous nodule in the lungs.

Original post: New software identifies and stratifies risk posed by lung nodules

]]> http://Cancernewsdigest.com/general-cancer/new-software-identifies-and-stratifies-risk-posed-by-lung-nodules/feed/ 0 Progression Of Barrett’s Esophagus To Esophageal Adenocarcinoma May Be Predicted By Biomarkers http://Cancernewsdigest.com/general-cancer/progression-of-barretts-esophagus-to-esophageal-adenocarcinoma-may-be-predicted-by-biomarkers/ http://Cancernewsdigest.com/general-cancer/progression-of-barretts-esophagus-to-esophageal-adenocarcinoma-may-be-predicted-by-biomarkers/#comments Fri, 08 Mar 2013 17:31:10 +0000 http://Cancernewsdigest.com/uncategorized/progression-of-barretts-esophagus-to-esophageal-adenocarcinoma-may-be-predicted-by-biomarkers/ A series of microRNA expression signatures that may help to define progression of the precancerous condition Barrett’s esophagus into esophageal adenocarcinoma was reported recently in Cancer Prevention Research, a journal of the American Association for Cancer Research…

See the original post here: Progression Of Barrett’s Esophagus To Esophageal Adenocarcinoma May Be Predicted By Biomarkers

]]> http://Cancernewsdigest.com/general-cancer/progression-of-barretts-esophagus-to-esophageal-adenocarcinoma-may-be-predicted-by-biomarkers/feed/ 0 What Is Stomach Cancer? What Is Gastric Cancer? http://Cancernewsdigest.com/general-cancer/what-is-stomach-cancer-what-is-gastric-cancer/ http://Cancernewsdigest.com/general-cancer/what-is-stomach-cancer-what-is-gastric-cancer/#comments Thu, 07 Mar 2013 23:31:22 +0000 http://Cancernewsdigest.com/uncategorized/what-is-stomach-cancer-what-is-gastric-cancer/ Stomach cancer, also known as gastric cancer, is the accumulation of an abnormal (malignant, cancerous) group of cells that form a tumor in any part of the stomach – in most cases, it refers to cancer that starts off in the mucus-producing cells on the lining of the inside of the stomach (adenocarcinoma)…

See the rest here: What Is Stomach Cancer? What Is Gastric Cancer?

]]> http://Cancernewsdigest.com/general-cancer/what-is-stomach-cancer-what-is-gastric-cancer/feed/ 0 Gene may help predict best chemotherapy treatment for pancreatic cancer patients http://Cancernewsdigest.com/general-cancer/gene-may-help-predict-best-chemotherapy-treatment-for-pancreatic-cancer-patients/ http://Cancernewsdigest.com/general-cancer/gene-may-help-predict-best-chemotherapy-treatment-for-pancreatic-cancer-patients/#comments Wed, 06 Feb 2013 05:32:32 +0000 http://Cancernewsdigest.com/uncategorized/gene-may-help-predict-best-chemotherapy-treatment-for-pancreatic-cancer-patients/ Researchers have identified a gene that may better predict survival for pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States. The scientists conducted a study that better defines the role of ribonucleotide reductase M1 (RRM1). The RRM1 gene encodes the regulatory subunit of ribonucleotide reductase, the molecular target of gemcitabine, a commonly used chemotherapy in pancreatic cancer.

Visit link: Gene may help predict best chemotherapy treatment for pancreatic cancer patients

]]> http://Cancernewsdigest.com/general-cancer/gene-may-help-predict-best-chemotherapy-treatment-for-pancreatic-cancer-patients/feed/ 0 What is Prostate Cancer? – Adenocarcinoma de prostata? http://Cancernewsdigest.com/prostate-cancer/what-is-prostate-cancer-adenocarcinoma-de-prostata/ http://Cancernewsdigest.com/prostate-cancer/what-is-prostate-cancer-adenocarcinoma-de-prostata/#comments Tue, 02 Oct 2012 04:37:18 +0000 http://Cancernewsdigest.com/uncategorized/what-is-prostate-cancer-adenocarcinoma-de-prostata/ what is Adenocarcinoma de prostata? A cancer that starts in the prostate gland. Most common cause of death from cancer in men over the age of 75, very rare in men that are younger than 40 years old. hepatocellular-carcinoma.com hepatocellular-carcinoma.com

http://www.youtube.com/v/GMN6EKyG4Xs?version=3&f=videos&app=youtube_gdata

Continued here: What is Prostate Cancer? – Adenocarcinoma de prostata?

]]> http://Cancernewsdigest.com/prostate-cancer/what-is-prostate-cancer-adenocarcinoma-de-prostata/feed/ 0 Mirena® ± Metformin for the Treatment of Early Endometrial Cancer http://Cancernewsdigest.com/cancer-clinical-trials/mirena-%c2%b1-metformin-for-the-treatment-of-early-endometrial-cancer/ http://Cancernewsdigest.com/cancer-clinical-trials/mirena-%c2%b1-metformin-for-the-treatment-of-early-endometrial-cancer/#comments Wed, 19 Sep 2012 16:33:23 +0000 http://Cancernewsdigest.com/uncategorized/mirena-%c2%b1-metformin-for-the-treatment-of-early-endometrial-cancer/ Conditions:   Complex Endometrial Hyperplasia With Atypia;   Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions:   Drug: Levonorgestrel;   Drug: Metformin
Sponsors:   Queensland Centre for Gynaecological Cancer;   Queensland Centre for Gynaecological Cancer;   The University of Queensland
Not yet recruiting – verified September 2012

Here is the original post: Mirena® ± Metformin for the Treatment of Early Endometrial Cancer

]]> http://Cancernewsdigest.com/cancer-clinical-trials/mirena-%c2%b1-metformin-for-the-treatment-of-early-endometrial-cancer/feed/ 0 Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies http://Cancernewsdigest.com/cancer-clinical-trials/combining-mln8237-with-nab-paclitaxel-in-patients-with-advanced-solid-malignancies/ http://Cancernewsdigest.com/cancer-clinical-trials/combining-mln8237-with-nab-paclitaxel-in-patients-with-advanced-solid-malignancies/#comments Tue, 04 Sep 2012 16:33:22 +0000 http://Cancernewsdigest.com/uncategorized/combining-mln8237-with-nab-paclitaxel-in-patients-with-advanced-solid-malignancies/ Condition:   Adenocarcinoma
Interventions:   Drug: MLN8237 + Abraxane;   Drug: MLN8237 + Abraxane;   Drug: MLN8237 + Abraxane;   Drug: MLN8237 + Abraxane
Sponsors:   Washington University School of Medicine;   Washington University School of Medicine
Not yet recruiting – verified August 2012

See the original post: Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

]]> http://Cancernewsdigest.com/cancer-clinical-trials/combining-mln8237-with-nab-paclitaxel-in-patients-with-advanced-solid-malignancies/feed/ 0 A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer http://Cancernewsdigest.com/cancer-clinical-trials/a-phase-ii-study-of-sig12d-loder-in-combination-with-chemotherapy-in-patients-with-unresectable-locally-advanced-pancreatic-cancer/ http://Cancernewsdigest.com/cancer-clinical-trials/a-phase-ii-study-of-sig12d-loder-in-combination-with-chemotherapy-in-patients-with-unresectable-locally-advanced-pancreatic-cancer/#comments Thu, 30 Aug 2012 16:32:10 +0000 http://Cancernewsdigest.com/uncategorized/a-phase-ii-study-of-sig12d-loder-in-combination-with-chemotherapy-in-patients-with-unresectable-locally-advanced-pancreatic-cancer/ Conditions:   Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions:   Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
Sponsors:   Silenseed Ltd;   Silenseed Ltd
Not yet recruiting – verified August 2012

See original here: A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer

]]> http://Cancernewsdigest.com/cancer-clinical-trials/a-phase-ii-study-of-sig12d-loder-in-combination-with-chemotherapy-in-patients-with-unresectable-locally-advanced-pancreatic-cancer/feed/ 0 Global ‘epidemic’ of gullet cancer seems to have started in UK in 1950s http://Cancernewsdigest.com/general-cancer/global-epidemic-of-gullet-cancer-seems-to-have-started-in-uk-in-1950s/ http://Cancernewsdigest.com/general-cancer/global-epidemic-of-gullet-cancer-seems-to-have-started-in-uk-in-1950s/#comments Fri, 24 Aug 2012 04:31:03 +0000 http://Cancernewsdigest.com/uncategorized/global-epidemic-of-gullet-cancer-seems-to-have-started-in-uk-in-1950s/ The global “epidemic” of one type of gullet cancer (adenocarcinoma) seems to have started in the UK during the 1950s, sparked by some as yet unknown, but common, factor, suggests new research.

View post: Global ‘epidemic’ of gullet cancer seems to have started in UK in 1950s

]]> http://Cancernewsdigest.com/general-cancer/global-epidemic-of-gullet-cancer-seems-to-have-started-in-uk-in-1950s/feed/ 0 LY2090314 With Gemcitabine Hydrochloride or FOLFOX Combination Chemotherapy in Treating Patients With Untreated, Metastatic Pancreatic Cancer http://Cancernewsdigest.com/cancer-clinical-trials/ly2090314-with-gemcitabine-hydrochloride-or-folfox-combination-chemotherapy-in-treating-patients-with-untreated-metastatic-pancreatic-cancer/ http://Cancernewsdigest.com/cancer-clinical-trials/ly2090314-with-gemcitabine-hydrochloride-or-folfox-combination-chemotherapy-in-treating-patients-with-untreated-metastatic-pancreatic-cancer/#comments Thu, 23 Aug 2012 16:32:36 +0000 http://Cancernewsdigest.com/uncategorized/ly2090314-with-gemcitabine-hydrochloride-or-folfox-combination-chemotherapy-in-treating-patients-with-untreated-metastatic-pancreatic-cancer/ Conditions:   Duct Cell Adenocarcinoma of the Pancreas;   Stage IV Pancreatic Cancer
Interventions:   Drug: LY2090314;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Other: pharmacological study;   Other: laboratory biomarker analysis
Sponsors:   Mayo Clinic;   Mayo Clinic;   National Cancer Institute (NCI)
Not yet recruiting – verified August 2012

Continue reading here: LY2090314 With Gemcitabine Hydrochloride or FOLFOX Combination Chemotherapy in Treating Patients With Untreated, Metastatic Pancreatic Cancer

]]> http://Cancernewsdigest.com/cancer-clinical-trials/ly2090314-with-gemcitabine-hydrochloride-or-folfox-combination-chemotherapy-in-treating-patients-with-untreated-metastatic-pancreatic-cancer/feed/ 0